Angle Up
0
Skip to Content
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
Folder: About Us
Back
ICC Members
ICC Committees
Contact
Folder: Treatment Guidelines
Back
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
Folder: Patients
Back
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Folder: Industry
Back
Clinical Trial Committee Chair
Folder: Healthcare Providers
Back
FOP Doctors and Specialists
Link to Clinical Trials
Folder: Media
Back
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
Introduction
Civiane Chung 2025-01-08 Civiane Chung 2025-01-08

Introduction

Excerpt would go here.

Read More
1. Abstract
Civiane Chung 2025-01-07 Civiane Chung 2025-01-07

1. Abstract

Excerpt would go here.

Read More
2. Executive Summary of Key Practice Points
Civiane Chung 2025-01-06 Civiane Chung 2025-01-06

2. Executive Summary of Key Practice Points

Excerpt would go here.

Read More
3. The Clinical and Basic Science Background of FOP 
Civiane Chung 2025-01-06 Civiane Chung 2025-01-06

3. The Clinical and Basic Science Background of FOP 

Excerpt would go here.

Read More
4. The Pathologic and Pathophysiologic-Based Treatment of FOP 
Civiane Chung 2025-01-01 Civiane Chung 2025-01-01

4. The Pathologic and Pathophysiologic-Based Treatment of FOP 

Read More
5. Special Medical Considerations in FOP
Civiane Chung 2024-12-28 Civiane Chung 2024-12-28

5. Special Medical Considerations in FOP

Read More
6. Current Treatment Considerations
Civiane Chung 2024-12-27 Civiane Chung 2024-12-27

6. Current Treatment Considerations

Read More
7. Classes of Medications
Civiane Chung 2024-12-25 Civiane Chung 2024-12-25

7. Classes of Medications

Read More
8. Emergency Guidelines for First Responders, Physicians & Dentists
Civiane Chung 2024-12-23 Civiane Chung 2024-12-23

8. Emergency Guidelines for First Responders, Physicians & Dentists

Read More
9. Conclusions
Civiane Chung 2024-12-22 Civiane Chung 2024-12-22

9. Conclusions

Read More
10. Acknowledgments
Civiane Chung 2024-12-21 Civiane Chung 2024-12-21

10. Acknowledgments

Read More
11. Disclosures
Civiane Chung 2024-12-19 Civiane Chung 2024-12-19

11. Disclosures

Read More
12. Authors’ Contact Information
Civiane Chung 2024-12-18 Civiane Chung 2024-12-18

12. Authors’ Contact Information

Read More

Join our mailing list

Sign up to receive updates from us.

© 2025 The International Clinical Council (ICC) on Fibrodysplasia Ossificans Progressiva (FOP).